A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have recently ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring prostate cancer. This dual the ...

We know that aerobic exercise – anything that gets you sweaty, your heart rate up or out of breath for 20 minutes a day – is ...

MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

Prostate cancer is often referred to as a silent threat because, for many men, the early signs can be subtle. Men need to get ...

A recent study showed that regular PSA testing of men over 50 could reduce deaths by 13%, a similar benefit to breast ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Currently, the UK lacks a national, population-wide screening programme for the disease, despite persistent calls from cancer ...

Men with recurrent prostate cancer may live longer. A trial shows enzalutamide and leuprolide reduce death risk by over 40% ...